Terminology Service < Semantic Lookup Platform

All terms in GO

Label	Id	Description
transmembrane-ephrin receptor activity	GO_0005005	[Combining with a transmembrane ephrin to initiate a change in cell activity.]
epidermal growth factor-activated receptor activity	GO_0005006	[Combining with an epidermal growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.]
epidermal growth factor binding	GO_0048408	[Interacting selectively and non-covalently with epidermal growth factor.]
epidermal growth factor receptor signaling pathway	GO_0007173	[A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.]
fibroblast growth factor-activated receptor activity	GO_0005007	[Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.]
fibroblast growth factor binding	GO_0017134	[Interacting selectively and non-covalently with a fibroblast growth factor.]
fibroblast growth factor receptor signaling pathway	GO_0008543	[The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.]
hepatocyte growth factor-activated receptor activity	GO_0005008	[Combining with hepatocyte growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.]
hepatocyte growth factor binding	GO_0036458	[Interacting selectively and non-covalently with a hepatocyte growth factor.]
hepatocyte growth factor receptor signaling pathway	GO_0048012	[The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands.]
insulin-activated receptor activity	GO_0005009	[Combining with insulin and transmitting the signal across the plasma membrane to initiate a change in cell activity.]
insulin binding	GO_0043559	[Interacting selectively and non-covalently with insulin, a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.]
insulin receptor signaling pathway	GO_0008286	[The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.]
glucuronate catabolic process to xylulose 5-phosphate	GO_0019640	[The chemical reactions and pathways resulting in the breakdown of glucuronate into other compounds, including xylulose 5-phosphate.]
glucuronate catabolic process	GO_0006064	[The chemical reactions and pathways resulting in the breakdown of glucuronate, any salt or ester of glucuronic acid.]
xylulose 5-phosphate biosynthetic process	GO_1901159	[The chemical reactions and pathways resulting in the formation of xylulose 5-phosphate.]
GO_0019641	GO_0019641
GO_0019642	GO_0019642
reductive tricarboxylic acid cycle	GO_0019643	[A pathway leading to the fixation of two molecules of CO2 and the production of one molecule of acetyl-CoA; essentially the oxidative TCA cycle running in reverse. Acetyl-CoA is reductively carboxylated to pyruvate, from which all other central metabolites can be formed. Most of the enzymes of reductive and oxidative TCA cycle are shared, with the exception of three key enzymes that allow the cycle to run in reverse: ATP citrate lyase, 2-oxoglutarate:ferredoxin oxidoreductase, and fumarate reductase. 2-oxoglutarate:ferredoxin oxidoreductase catalyzes the carboxylation of succinyl-CoA to 2-oxoglutarate, ATP citrate lyase the ATP-dependent cleavage of citrate to acetyl-CoA and oxaloacetate, and fumarate reductase the reduction of fumarate forming succinate.]
carbon fixation	GO_0015977	[A metabolic process in which carbon (usually derived from carbon dioxide) is incorporated into organic compounds (usually carbohydrates).]